Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Granulomatous Disease, Chronic
- Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists
- A Pilot Study of Fecal Microbiota Transplantation for Chronic Granulomatous Disease-Associated Colitis
- A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications
- IL-1 Receptor Inhibitor for Granulomatous Complications in Patients With Chronic Granulomatous Disease
- Vitamin D3 For CGD Patients With BCGosis/Itis
- Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide
- Plerixafor/G-CSF as Additional Agents for Conditioning Before HSCT in CGD Patients
- Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
- Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
- Pioglitazone Therapy for Chronic Granulomatous Disease
- Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGD
- High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease
- Effect of IFN-γ on Innate Immune Cells
- Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells
- Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant Cyclophosphamide
- Bone Marrow Transplant With Abatacept for Non-Malignant Diseases
- Immune Disorder HSCT Protocol
- Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
- Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in Chronic Granulomatous Disease(CGD)
- Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation
- Biochemical Response to Interferon-Gamma in Subjects With Specific Gene Mutation in Chronic Granulomatous Disease
- Pharmacokinetics of Posaconazole in Children With Chronic Granulomatous Disease (CGD)
- Gene Therapy for Chronic Granulomatous Disease in Korea
- Matched Unrelated or Non-Genotype Identical Related Donor Transplantation For Chronic Granulomatous Disease
- Gene Therapy for Chronic Granulomatous Disease
- Gene Therapy for Chronic Granulomatous Disease
- Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
- Posaconazole to Treat Invasive Fungal Infections
- Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of Care
- Study of Total Body Irradiation and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation in Combination With Cyclosporine and Mycophenolate Mofetil in Patients With Inherited Disorders
- Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
- Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up
- A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood
- Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease